• Panobinostat (LBH589): Reliable HDAC Inhibition for Cancer A

  2026-05-09

  This article delivers scenario-driven, evidence-based guidance for researchers using Panobinostat (LBH589), SKU A8178, in cell viability, proliferation, and apoptosis assays. It addresses common lab challenges, protocol optimization, and the scientific justification behind choosing APExBIO Panobinostat for reproducible results in epigenetic and oncology research.

• Nicotinamide Riboside Chloride: Powering Reliable RGC Models

  2026-05-08

  Leverage Nicotinamide Riboside Chloride (NIAGEN) for enhanced reproducibility and metabolic fidelity in stem cell-derived retinal ganglion cell (RGC) workflows. This guide delivers protocol-ready parameters, troubleshooting insights, and translational context for metabolic dysfunction and neurodegenerative disease research.

• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2026-05-08

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) addresses the need for precise, visually distinct molecular weight standards during SDS-PAGE and Western blotting. Its EDTA-free formulation and multi-color banding support compatibility with advanced workflows, such as Phosbind SDS-PAGE and fluorescent membrane imaging. This product is not intended for applications outside protein electrophoresis or where an unstained marker is specifically required.

• Annexin V-Cy5/DAPI Apoptosis Kit: Mechanistic Precision in L

  2026-05-07

  Discover how the Annexin V-Cy5/DAPI Apoptosis Kit empowers researchers to dissect mitochondrial apoptosis in leukemia models with unparalleled specificity. This article uniquely integrates mechanistic insights from recent P2RX1 research, guiding optimal assay selection and interpretation.

• MEK1/2 and c-Myc-Max Control of TERT in Human Stem Cells

  2026-05-07

  This study uncovers the cooperative role of MEK1/2 kinases and the c-Myc-Max transcriptional complex in maintaining active TERT expression in human pluripotent stem cells by opposing polycomb-mediated repression. These findings provide mechanistic insight into telomerase regulation and offer a foundation for targeted modulation of stem cell proliferative capacity.

• N6-Methyl-dATP: Precision Tools for DNA Replication Fidelity

  2026-05-06

  N6-Methyl-dATP empowers researchers to dissect DNA replication fidelity and methylation-driven genomic stability with unprecedented precision. Discover how this APExBIO reagent streamlines workflows in leukemia modeling and epigenetics, bridging bench research and translational applications.

• AO/PI Staining Solution: Benchmarking Fluorescent Cell Viabi

  2026-05-06

  AO/PI Staining Solution enables precise live/dead cell discrimination using dual fluorescent DNA dyes, significantly outperforming traditional stains in accuracy. Its robust protocol is optimized for fluorescence-based cell counting and membrane integrity assays, delivering reliable results for both routine and advanced research applications.

• Ibrexafungerp (MK 3118): Precision Antifungal Strategy for T

  2026-05-05

  This article presents a thought-leadership perspective on Ibrexafungerp (MK 3118), blending mechanistic, experimental, and translational insights to guide researchers confronting resistant Candida infections. Integrating robust evidence on its unique mode of action and preserved potency at low pH, we provide actionable protocol parameters, competitive context, and a forward-looking vision for antifungal innovation.

• Enhanced Lysosomal Exocytosis Drives Cartilage Pathology in

  2026-05-05

  This research uncovers the role of enhanced lysosomal exocytosis and altered growth factor signaling in cartilage pathology using a zebrafish model of mucopolysaccharidosis type IVA (MPS IVA). The findings challenge the traditional view that substrate accumulation alone drives pathology in lysosomal storage disorders, highlighting the importance of lysosomal membrane trafficking and protease-mediated signaling disruption.

• 10058-F4: Precision Disruption of c-Myc-Max for Advanced Can

  2026-05-04

  Explore how 10058-F4, a potent c-Myc-Max dimerization inhibitor, enables targeted manipulation of oncogenic transcription and apoptosis in complex cancer models. This article uniquely integrates new mechanistic insights with practical assay guidance.

• Ceftolozane/Tazobactam: Innovation in Gram-Negative Resistan

  2026-05-04

  The referenced paper details ceftolozane/tazobactam’s novel approach to treating multidrug-resistant gram-negative infections by combining a potent cephalosporin with a β-lactamase inhibitor. This review underscores the clinical significance of targeted pharmacokinetics and resistance coverage, shaping future antibacterial strategies.

• SP2509: Lysine-Specific Demethylase 1 Antagonist in AML Rese

  2026-05-03

  SP2509 is a highly selective Lysine-specific demethylase 1 antagonist that empowers researchers to interrogate epigenetic mechanisms and drive apoptosis induction in AML cells. Its robust performance and workflow adaptability make SP2509 a foundational tool for acute myeloid leukemia research and advanced cancer epigenetics studies.

• Cytarabine (AraC): Mechanisms, Benchmarks, and Research Inte

  2026-05-02

  Cytarabine (AraC) is a nucleoside analog DNA synthesis inhibitor and a benchmark apoptosis inducer in leukemia research. Its efficacy depends on deoxycytidine kinase activation for DNA incorporation and p53-mediated apoptosis. This article details its verified mechanisms, experimental benchmarks, and integration in advanced research workflows.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–Host Receptor

  2026-05-01

  This study reveals that naturally occurring angiotensin peptides, including short fragments such as Angiotensin 1/2 (5-7), significantly enhance binding of the SARS-CoV-2 spike protein to host cell receptors, particularly AXL. The findings suggest an underappreciated mechanistic link between the renin-angiotensin system and viral entry pathways, with implications for COVID-19 pathogenesis and therapeutic targeting.

• Nocodazole: Microtubule Polymerization Inhibitor in Cell Cyc

  2026-05-01

  Nocodazole is a potent, reversible microtubule polymerization inhibitor central to cell cycle regulation and microtubule dynamics research. Its direct β-tubulin binding enables precise cell cycle arrest and apoptosis induction in cancer studies. APExBIO’s A8487 product offers validated utility for reproducible research applications.

15864 records 1/1058 page Next 12345 下5页 Last page